EA
CLB icon

Emerald Acquisition’s Core Laboratories CLB Stock Holding History

Emerald Acquisition’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$95M Sell
846,103
-46,458
-5% -$5.35M 0.18% 121
2016
Q2 		$111M Buy
+892,561
New +$108M 0.19% 118

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Emerald Acquisition's CLB Position: Q3 2016 in Review

Emerald Acquisition reduced its Core Laboratories (CLB) stake by 5.2% in Q3 2016, selling an estimated $5.35M and leaving 846,103 shares worth $95M. The position accounts for 0.18% of the portfolio, ranked #121.

Emerald Acquisition first reported a position in CLB in Q2 2016 and has held it in 2 quarters since. The position peaked at $111M in Q2 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Emerald Acquisition held 846,103 shares of Core Laboratories worth $95M as of Q3 2016.
  • Emerald Acquisition sold 46,458 Core Laboratories shares in Q3 2016, an estimated $5.35M.
  • Core Laboratories made up 0.18% of Emerald Acquisition's portfolio in Q3 2016, its #121 holding.
  • Emerald Acquisition first reported a position in Core Laboratories in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Core Laboratories position peaked at $111M in Q2 2016.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.